Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Advanced Human Imaging ( (AU:AHI) ) has shared an announcement.
Advanced Health Intelligence Ltd has announced its ongoing efforts to restore compliance with the ASX and NASDAQ exchanges following the delisting of its American Depositary Shares from NASDAQ due to shareholder equity deficiencies. The company is focused on reinstating its securities on the ASX by completing outstanding financial audits and governance submissions, which are prerequisites for any potential relisting on NASDAQ. AHI is actively seeking funding to meet these requirements and aims to demonstrate financial stability and governance readiness to regain its market position. The company has set a deadline to release its FY2024 Annual Report by 30 September 2025 to avoid removal from the ASX official list.
More about Advanced Human Imaging
Advanced Health Intelligence Ltd (AHI) operates in the digital health industry, offering innovative smartphone-based health risk identification solutions. These solutions allow individuals to conduct comprehensive health assessments using smartphone sensor technology, identifying risk markers for various health conditions. AHI’s technology facilitates data sharing with healthcare providers, insurers, employers, and government agencies, enhancing care pathways. The company is known for its pioneering work in using smartphones for digital health, supported by a team of experts in machine learning, artificial intelligence, and clinical expertise.
Technical Sentiment Signal: Sell
Current Market Cap: A$20.52M
See more insights into AHI stock on TipRanks’ Stock Analysis page.